Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Jun 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 107174201000001111 | Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 107174301000001119 | Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 2 (CD) | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Is a | Oxycodone 15mg modified-release tablets 56 tablet | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Has AMP | Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Has excipient | Lactose | false | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Has excipient | Stearyl alcohol | false | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Has specific active ingredient | Oxycodone hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Has dispensed dose form | Modified-release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
| Renocontin 15mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR